Injected drug for advanced solid tumors
Part of Cancer clinical trials.
This trial tests an investigational drug injected directly into advanced solid tumors to see if it is safe and effective. It is for people whose cancer has not responded to standard treatment or who cannot tolerate it.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 to 75 years old.
- You have an advanced solid tumor (like breast, melanoma, head and neck, colorectal, bile duct, pancreatic, or liver cancer) that has grown despite standard treatment, or you cannot take standard treatment.
- You have at least one tumor that can be safely injected, either near the skin surface or with imaging guidance.
- You are able to care for yourself and do light activities (ECOG score 0 or 1).
- Your doctor expects you to live at least 3 months.
- Your heart, liver, kidney, and blood counts are within acceptable ranges.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new drug called IDOV-SAFE given through a vein. It is for people with advanced solid tumors that have not responded to standard treatments. The study aims to see if the drug is safe and if it can help shrink tumors.
This trial tests a new intravenous drug called IDOV-SAFE in people with advanced solid tumors that have stopped responding to standard treatments or have no effective standard option. The goal is to see if it is safe and effective.
This trial tests an investigational drug called IDOV-Immune for people with advanced solid tumors that have stopped responding to standard treatments. The goal is to see if it is safe and effective.
This trial tests an investigational drug for people with advanced digestive system cancers (like colorectal, stomach, or liver cancer) that have stopped responding to standard treatments. The goal is to see if the drug is safe and helps control the cancer.
This trial tests an experimental virus-based treatment for people with advanced solid tumors that have stopped responding to standard therapies. The treatment is designed to infect and destroy cancer cells while boosting the immune system.
This trial tests an experimental therapy that combines a new drug (OVV-01) given intravenously and injected directly into tumors, along with another immunotherapy drug (AK112). It's for people with advanced solid tumors who have run out of standard options, and it aims to see if the combination can shrink tumors or slow their growth.
Hear when a new Advanced Malignant Solid Neoplasm trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.